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BACKGROUND
The implementation of effective policies that reduce the
prevalence of smoking has substantial economic benefit
for Australia. This article describes how methods for
estimating the social costs of smoking were developed and
how these methods have been applied to the Australian
population and to measure the effect of interventions to
reduce smoking prevalence in some states.
For many years, the major dispute between the tobacco
industry and the public health community was over the
issue of whether smoking caused morbidity and premature
mortality, or whether there was simply a statistical
association without a causal connection. In the face of
the type of evidence comprehensively surveyed in several
recent international and Australian meta-analyses, and
particularly in the light of admissions about causality
contained in now public internal tobacco industry
documents,  the industry has been forced to concede defeat
on this front.
As a reaction, the industry has shifted the main thrust of
its defence to economic arguments, asserting for example
that:
• smokers make fully-informed, rational decisions to
smoke, and so have decided that the benefits to them
of smoking outweigh any costs that they may bear as
a consequence of their tobacco consumption;
• any smoking-attributable costs that may be borne by
the community are outweighed by community
benefits, such as the pleasure that smokers enjoy and
the tobacco tax revenue received by governments;
• the tobacco industry confers great benefits on the
community, because it generates substantial
employment in the manufacture and distribution of
cigarettes.
These assertions may appear to be plausible and yet, when
subject to the rigours of economic analysis, are usually
shown to be false.
An important basis for economic discussion of the effect
of smoking is information on its economic costs to the
community as a whole. This information is required to
demonstrate the size of the policy problem; without it, it
is difficult to estimate the potential economic returns to
public anti-smoking policies or to evaluate individual
anti-smoking policies or programs.
For more than a decade, we have been engaged in research
on the social costs in Australia of smoking as well as those
for the use of alcohol and illicit drugs. The quality and
coverage of these estimates have improved as the quality
of the data has improved and the estimation methodology
has been refined. This refinement has benefited from the
international exchange of ideas with economists engaged
in producing cost studies in other countries, culminating
in the publication by the World Health Organization of
international guidelines for estimating the costs of
substance abuse.1 We have also benefited from
developments in Australian epidemiological research,
which represents a fundamental data requirement for this
type of study.
Since 1991, we have produced for the National Drug
Strategy a series of three monographs describing the social
costs of drug abuse in Australia, disaggregating the costs
by type of drug. These reports are:
• Estimating the economic costs of drug abuse,2 which
was the first attempt in Australia to produce
comprehensive estimates of the social costs of drug
abuse, and one of the first world-wide. The social costs
of drug abuse were estimated for the calendar year
1988. The research was based on epidemiological work
undertaken at the University of Western Australia that
quantified drug-attributable mortality and morbidity.3
• The social costs of drug abuse in Australia in 1988
and 1992,4 which presented social cost estimates for
1992 on the basis of a new meta-analysis from the
University of Western Australia,5 newly available
casemix health care cost data and other improved data.
The report also presented revised estimates for 1988
on a basis consistent with the new 1992 estimates.
Thus it was possible to gain an indication of how the
social costs of drug abuse (including tobacco) were
changing over time.
• Counting the cost: estimates of the social costs of drug
abuse in Australia in 1998–99,6 which presented new
estimates for the financial year 1998–99 on the basis
of a revised meta-analysis produced by the Australian
Institute of Health and Welfare,7 and improved data
from other areas. The range of smoking-attributable
costs estimated was extended to include involuntary
smoking, workplace absenteeism, pharmaceuticals,
and fires. Because of the increased range of the
estimates, the 1998–99 figures are not directly
comparable to earlier estimates.
INTERPRETING SOCIAL COST ESTIMATES
The smoking costs estimated in these studies are social
costs (often called external costs), as opposed to private
costs. For costs to be defined as private costs two important
conditions must be simultaneously satisfied:
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• smokers must themselves bear the full costs of smoking
that they generate, including most importantly health
and productivity costs;
• smokers must be fully informed about the effects and
costs of their smoking, and they must have made
rational decisions to smoke in the light of the full
information available to them.
Since it is most unlikely in the Australian context that
these two conditions are simultaneously satisfied, virtually
all the costs imposed by smokers, even on themselves,
can be considered to be social costs.
These types of studies concentrate on estimation of social,
rather than private, costs and benefits because it is the
social measures that provide the basis for public policy. If
individual decisions to smoke were made rationally on a
fully informed basis, and if the individual smokers
themselves bore all the costs that their smoking caused,
then their decisions could be assumed to accord with their
own self-interest with no one else being affected. In these
unlikely circumstances, government intervention could
not improve the lot of the smokers or of anyone else.
However, if these conditions are not satisfied, that is, if
social costs exist, government intervention has the
potential to improve the welfare of the community as a
whole.
METHOD
Two broad techniques are available to estimate the social
costs of drug abuse: the ‘human capital’ approach and the
‘demographic’ approach. The key difference between the
two is the way in which the costs of premature mortality
are treated. In the human capital approach, the lost value
of a deceased worker’s production is represented by the
discounted present value of the future time stream of lost
production. The demographic approach uses a comparison
of the actual population with the hypothetical alternative
population that would have existed had there been no
drug abuse. Thus, the human capital approach produces
an estimate of the present and future costs due to drug-
related mortality in the current year, while the demographic
approach estimates the present costs of drug-related
mortality in past and present years.1
Our social cost estimates are based on the demographic
method which, it can be argued, provides results that are
easier to understand than those estimated by the human
capital method. The current size and structure
(disaggregated by age and sex) of the Australian population
are compared with those that would have existed in a
theoretically-counterfactual situation in which there had
been no smoking in the previous 40 years. It then becomes
possible to compare the two populations for such
characteristics as labour force size and structure, and the
demand for health care, and so to estimate the social costs
borne in the year under review as a result of past and
present smoking. This type of analysis requires not only
epidemiological information but also demographic
analysis, and is most efficiently conducted by teams that
include a range of skills rather than by economists working
alone. It cannot be effectively conducted without
substantial economic input, although regrettably there
are various examples in the literature where this has been
attempted. The economic issues in this type of research
should not be underestimated, as is clearly demonstrated
in the International Guidelines.1
We have extended the range of these types of studies to
incorporate estimates of:
• Avoidable costs—the proportion of aggregate social
costs that might be prevented over time by appropriate
anti-smoking policies;
• Budgetary costs—the effect of smoking on
government budgets rather than on the community as
a whole;
• Incidence of social costs—the disaggregation of the
costs between various community sectors (individuals,
business and government).
RESULTS
Table 1 summarises the most recent estimates of the social
costs of smoking in Australia for the financial year 1998–99.
Some further results were:
• a high proportion of the health effects of involuntary
smoking was borne by the young or the unborn;
• of the total costs estimated for all forms of drug abuse
(excluding abuse of pharmaceuticals) in Australia in
1998–99, smoking is by far the largest contributor,
accounting for 61 per cent of the total. Alcohol
accounted for 22 per cent and illicit drugs accounted
for 17 per cent;
• the avoidable costs of smoking represented 45 per cent
of total costs;
TABLE 1
ESTIMATE OF THE SOCIAL COST OF SMOKING
FOR THE FINANCIAL YEAR, AUSTRALIA, 1998–99
$ million $  million
Tangible costs
Lost production (net) 5,064
Health care 1,095
Fires * 26
Resources used in
cigarette production 1,402
Total tangible costs 7,587
Intangible costs
Value of loss of life 13,476
Total intangible costs 13,476
Total costs 21,063
* Not included under lost production or health care.
Source: Collins and Lapsley, 2002.6
NSW Public Health Bulletin Vol.  15   No. 5–694
• of the total tangible costs of smoking 59 per cent were
borne by individuals, 30 per cent were borne by
business, and only 11 per cent were borne by
governments. By their nature, all intangible costs (pain
and suffering and loss of life) are borne by individuals:
• smoking increased federal and state government
outlays by $885 million but increased tax revenues
by $3,647 million (taking into account some revenue
losses). Thus, governments gain a substantial
economic benefit from smoking while the community
as a whole bears very high economic costs greatly
exceeding revenue from tobacco taxes.
CONCLUSION
The authors are currently engaged in a research study for
the NSW Department of Health to estimate the social costs
of smoking in NSW, and the social benefits of reducing
the prevalence of smoking in NSW. We have also
undertaken studies for two other states of the benefits of
anti-smoking policies. These studies are:
• The social costs of tobacco in Victoria and the social
benefits of Quit Victoria,8 an estimate of the benefits
of expenditures on Quit Victoria, which indicated that
they had yielded a very high social rate of return in
Victoria;
• The social costs of tobacco in Western Australia and
the social benefits of reducing Western Australian
smoking prevalence,9 which estimated that the social
benefits of achieving the objective of the Western
Australian Target 15 campaign to reduce smoking
prevalence to 15 per cent would be greater by a
very considerable margin than the resources
currently expended on anti-smoking programs in
that State.
These results, together with our calculations of avoidable
smoking costs, show that the implementation of effective
policies to reduce smoking can have great economic
benefits for Australia.
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